Infection after total knee arthroplasty by M. catarrhalis associated with rheumatoid arthritis and DMARDs therapy

Moraxella catarrhalis is not commonly associated with prosthetic joint infection (PJI). We present the first case of a patient with rheumatoid arthritis on certolizumab, an anti-tumor necrosis factor therapy, who developed PJI following a total knee replacement.

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Bulletin of the NYU Hospital for Joint Diseases 2017-04, Vol.75 (2), p.140
Hauptverfasser: Evangelista, Perry J, Evangelista, Gregory T, Ogrich, Lauren M
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue 2
container_start_page 140
container_title Bulletin of the NYU Hospital for Joint Diseases
container_volume 75
creator Evangelista, Perry J
Evangelista, Gregory T
Ogrich, Lauren M
description Moraxella catarrhalis is not commonly associated with prosthetic joint infection (PJI). We present the first case of a patient with rheumatoid arthritis on certolizumab, an anti-tumor necrosis factor therapy, who developed PJI following a total knee replacement.
format Article
fullrecord <record><control><sourceid>gale_proqu</sourceid><recordid>TN_cdi_proquest_journals_1906058410</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A495667379</galeid><sourcerecordid>A495667379</sourcerecordid><originalsourceid>FETCH-LOGICAL-g950-5826cb0d6b526dc1aa9389191dbd63d104916975152bf6555d842e6c4e0f22563</originalsourceid><addsrcrecordid>eNptjV1LwzAUhosoOKf_IeB1R5I2aXM5Nj8GG4LsvpzmY83ski3JkP17OybqhZyL9_DyPOdcZSMiCp6LilbXPzsRt9ldjFuMOeO0HGWHhTNaJusdApN0QMkn6NGH0xpBSF3w-x5iOqH2hFYTJCFBCB30NiKI0UsLSSv0aVOHQqePO0jeqotp0xlyCs1X0_d5RKnTAfan--zGQB_1w3eOs_Xz03r2mi_fXhaz6TLfCIZzVlMuW6x4yyhXkgCIohZEENUqXiiCS0G4qBhhtDWcMabqkmouS40NpYwX4-zxcnYf_OGoY2q2_hjc8LEhAnPM6pLgX2oDvW6sMz4FkDsbZTMtBeO8KioxUJN_qGGU3lnpnTZ26P8IX64tcqU</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1906058410</pqid></control><display><type>article</type><title>Infection after total knee arthroplasty by M. catarrhalis associated with rheumatoid arthritis and DMARDs therapy</title><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><creator>Evangelista, Perry J ; Evangelista, Gregory T ; Ogrich, Lauren M</creator><creatorcontrib>Evangelista, Perry J ; Evangelista, Gregory T ; Ogrich, Lauren M</creatorcontrib><description>Moraxella catarrhalis is not commonly associated with prosthetic joint infection (PJI). We present the first case of a patient with rheumatoid arthritis on certolizumab, an anti-tumor necrosis factor therapy, who developed PJI following a total knee replacement.</description><identifier>ISSN: 1936-9719</identifier><identifier>EISSN: 1936-9727</identifier><language>eng</language><publisher>New York: J. Michael Ryan Publishing Co</publisher><subject>Antirheumatic agents ; Branhamella catarrhalis ; Complications and side effects ; Gram-negative bacterial infections ; Health aspects ; Infections ; Joint replacement surgery ; Knee ; Monoclonal antibodies ; Patient outcomes ; Physiological aspects ; Rheumatoid arthritis ; Risk factors ; Tumor necrosis factor-TNF</subject><ispartof>Bulletin of the NYU Hospital for Joint Diseases, 2017-04, Vol.75 (2), p.140</ispartof><rights>COPYRIGHT 2017 J. Michael Ryan Publishing Co.</rights><rights>Copyright J. Michael Ryan Publishing, Inc. 2017</rights><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784</link.rule.ids></links><search><creatorcontrib>Evangelista, Perry J</creatorcontrib><creatorcontrib>Evangelista, Gregory T</creatorcontrib><creatorcontrib>Ogrich, Lauren M</creatorcontrib><title>Infection after total knee arthroplasty by M. catarrhalis associated with rheumatoid arthritis and DMARDs therapy</title><title>Bulletin of the NYU Hospital for Joint Diseases</title><description>Moraxella catarrhalis is not commonly associated with prosthetic joint infection (PJI). We present the first case of a patient with rheumatoid arthritis on certolizumab, an anti-tumor necrosis factor therapy, who developed PJI following a total knee replacement.</description><subject>Antirheumatic agents</subject><subject>Branhamella catarrhalis</subject><subject>Complications and side effects</subject><subject>Gram-negative bacterial infections</subject><subject>Health aspects</subject><subject>Infections</subject><subject>Joint replacement surgery</subject><subject>Knee</subject><subject>Monoclonal antibodies</subject><subject>Patient outcomes</subject><subject>Physiological aspects</subject><subject>Rheumatoid arthritis</subject><subject>Risk factors</subject><subject>Tumor necrosis factor-TNF</subject><issn>1936-9719</issn><issn>1936-9727</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2017</creationdate><recordtype>article</recordtype><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><recordid>eNptjV1LwzAUhosoOKf_IeB1R5I2aXM5Nj8GG4LsvpzmY83ski3JkP17OybqhZyL9_DyPOdcZSMiCp6LilbXPzsRt9ldjFuMOeO0HGWHhTNaJusdApN0QMkn6NGH0xpBSF3w-x5iOqH2hFYTJCFBCB30NiKI0UsLSSv0aVOHQqePO0jeqotp0xlyCs1X0_d5RKnTAfan--zGQB_1w3eOs_Xz03r2mi_fXhaz6TLfCIZzVlMuW6x4yyhXkgCIohZEENUqXiiCS0G4qBhhtDWcMabqkmouS40NpYwX4-zxcnYf_OGoY2q2_hjc8LEhAnPM6pLgX2oDvW6sMz4FkDsbZTMtBeO8KioxUJN_qGGU3lnpnTZ26P8IX64tcqU</recordid><startdate>20170401</startdate><enddate>20170401</enddate><creator>Evangelista, Perry J</creator><creator>Evangelista, Gregory T</creator><creator>Ogrich, Lauren M</creator><general>J. Michael Ryan Publishing Co</general><general>J. Michael Ryan Publishing, Inc</general><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9.</scope><scope>M0S</scope><scope>M1P</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope></search><sort><creationdate>20170401</creationdate><title>Infection after total knee arthroplasty by M. catarrhalis associated with rheumatoid arthritis and DMARDs therapy</title><author>Evangelista, Perry J ; Evangelista, Gregory T ; Ogrich, Lauren M</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-g950-5826cb0d6b526dc1aa9389191dbd63d104916975152bf6555d842e6c4e0f22563</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2017</creationdate><topic>Antirheumatic agents</topic><topic>Branhamella catarrhalis</topic><topic>Complications and side effects</topic><topic>Gram-negative bacterial infections</topic><topic>Health aspects</topic><topic>Infections</topic><topic>Joint replacement surgery</topic><topic>Knee</topic><topic>Monoclonal antibodies</topic><topic>Patient outcomes</topic><topic>Physiological aspects</topic><topic>Rheumatoid arthritis</topic><topic>Risk factors</topic><topic>Tumor necrosis factor-TNF</topic><toplevel>online_resources</toplevel><creatorcontrib>Evangelista, Perry J</creatorcontrib><creatorcontrib>Evangelista, Gregory T</creatorcontrib><creatorcontrib>Ogrich, Lauren M</creatorcontrib><collection>ProQuest Central (Corporate)</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><jtitle>Bulletin of the NYU Hospital for Joint Diseases</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Evangelista, Perry J</au><au>Evangelista, Gregory T</au><au>Ogrich, Lauren M</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Infection after total knee arthroplasty by M. catarrhalis associated with rheumatoid arthritis and DMARDs therapy</atitle><jtitle>Bulletin of the NYU Hospital for Joint Diseases</jtitle><date>2017-04-01</date><risdate>2017</risdate><volume>75</volume><issue>2</issue><spage>140</spage><pages>140-</pages><issn>1936-9719</issn><eissn>1936-9727</eissn><abstract>Moraxella catarrhalis is not commonly associated with prosthetic joint infection (PJI). We present the first case of a patient with rheumatoid arthritis on certolizumab, an anti-tumor necrosis factor therapy, who developed PJI following a total knee replacement.</abstract><cop>New York</cop><pub>J. Michael Ryan Publishing Co</pub></addata></record>
fulltext fulltext
identifier ISSN: 1936-9719
ispartof Bulletin of the NYU Hospital for Joint Diseases, 2017-04, Vol.75 (2), p.140
issn 1936-9719
1936-9727
language eng
recordid cdi_proquest_journals_1906058410
source Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals
subjects Antirheumatic agents
Branhamella catarrhalis
Complications and side effects
Gram-negative bacterial infections
Health aspects
Infections
Joint replacement surgery
Knee
Monoclonal antibodies
Patient outcomes
Physiological aspects
Rheumatoid arthritis
Risk factors
Tumor necrosis factor-TNF
title Infection after total knee arthroplasty by M. catarrhalis associated with rheumatoid arthritis and DMARDs therapy
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-04T18%3A07%3A56IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_proqu&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Infection%20after%20total%20knee%20arthroplasty%20by%20M.%20catarrhalis%20associated%20with%20rheumatoid%20arthritis%20and%20DMARDs%20therapy&rft.jtitle=Bulletin%20of%20the%20NYU%20Hospital%20for%20Joint%20Diseases&rft.au=Evangelista,%20Perry%20J&rft.date=2017-04-01&rft.volume=75&rft.issue=2&rft.spage=140&rft.pages=140-&rft.issn=1936-9719&rft.eissn=1936-9727&rft_id=info:doi/&rft_dat=%3Cgale_proqu%3EA495667379%3C/gale_proqu%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1906058410&rft_id=info:pmid/&rft_galeid=A495667379&rfr_iscdi=true